前列腺动脉栓塞治疗前列腺新生体大规模吸收性出血:病例报告和系统审查
Lorenzo Moramarco1, Antonino M Grande2, Maurizio Vertemati3
1Radiologia-Neuroradiologia Diagnostica ed Interventistica, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Journal of clinical medicine
|January 11, 2024
概括
前列腺动脉栓塞 (PAE) 为因前列腺癌而经历严重出血和下泌尿道症状 (LUTS) 的男性提供安全有效的微创治疗. 这次审查突出了PAE的重点.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 干预性放射学 干预性放射学
- 在瘤学瘤学.
背景情况:
- 尿路下部症状 (LUTS) 和出血症在患有瘤的老年男性中普遍存在,特别是前列腺癌 (PCa).
- 患者经常有需要抗凝血剂/抗血栓剂的并发症,这使得像通过尿道切除前列腺 (TURP) 这样的治疗复杂化.
- 前列腺动脉栓塞 (PAE) 是一种最小的侵入性选择,用于管理良性前列腺激增症 (BPH) 和PCa中的LUTS和难治性出血.
研究的目的:
- 进行前列腺动脉栓塞 (PAE) 对前列腺瘤患者大规模和难治的出血症的叙述性审查.
- 评估PAE在这个患者群体中的长期结果,安全性和并发症管理.
- 介绍一种算法,用于治疗前列腺癌的老年男性难治出血.
主要方法:
- 从1976年到2023年6月对前列腺出血症的PAE进行叙事性文献综述.
- 包括最近的发展,前性队列研究和长期结果数据.
- 呈现病例报告和治疗难治出血的治疗算法.
主要成果:
- 在管理LUTS和巨大的难治性前列腺出血症方面,PAE显示出有前途的结果.
- 该审查侧重于耐用性,长期有效性,生活质量和静血控制.
- 对于服用抗凝血剂的患者来说,PAE被认为是高风险手术的安全替代品,例如TURP.
结论:
- 在前列腺瘤患者,特别是那些服用抗凝血剂的患者中,PAE是一种可行的和安全的替代方案,用于管理大规模难以治疗的出血症.
- 对长期结果和特定并发症管理的进一步研究是有必要的.
- 拟议的算法可以帮助在这个具有挑战性的患者群体治疗难治性出血.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
183
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
183
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
166
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
166